Immunotherapy bowel cancer drug works for 100% of patients – researchers

Research has suggested an immunotherapy drug could spare bowel cancer patients the need for surgery (Alamy/PA)

An immunotherapy drug could spare bowel cancer patients the need for surgery and chemotherapy after results showed it was effective in 100% of cases.

Jemperli (also called dostarlimab) from GSK showed “unprecedented results”, the firm said, with no evidence of disease in all patients treated.